Institutional investors purchased a net $3.0 million shares of ALIM during the quarter ended December 2017 and now own 46.91% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STONEPINE CAPITAL MANAGEMENT LLC Bought 3.1 Million shares of Alimera Sciences Inc
ARMISTICE CAPITAL LLC Bought 124.0 Thousand shares of Alimera Sciences Inc